X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-12-26 | GDV.M | Gabelli Dividend & Income Trust | Gabelli Mario J | Control Person of Adviser, 10% | P - Purchase | $10.00 | +5,818,500 | 14,230,000 | +69% | +$58,185,000 | ||||||
| M | 2025-12-29 | SLGL | Sol-Gel Technologies Ltd. | Opaleye Management Inc. | 10% | P - Purchase | $41.97 | +66,304 | 453,739 | +17% | +$2,782,904 | |||||
2025-11-26 | EFOI | Energy Focus, Inc/De | Huang Chiao Chieh | CEO, 10% | P - Purchase | $2.29 | +262,009 | 1,998,599 | +15% | +$600,001 | ||||||
2025-12-30 | LGL | Lgl Group Inc | Gabelli Mario J | 10% | P - Purchase | $4.75 | +95,387 | 1,072,999 | +10% | +$453,088 | ||||||
| M | 2025-12-29 | TPVG | Triplepoint Venture Growth Bdc Corp. | Labe James | CEO | P - Purchase | $6.39 | +52,410 | 2,001,495 | +3% | +$335,161 | |||||
| M | 2025-12-29 | TPVG | Triplepoint Venture Growth Bdc Corp. | Srivastava Sajal | Pres, CIO | P - Purchase | $6.39 | +52,410 | 2,065,938 | +3% | +$335,161 | |||||
2025-12-29 | IRD | Opus Genetics, Inc. | Gallagher Cam | Dir | P - Purchase | $1.97 | +164,000 | 2,007,430 | +9% | +$323,693 | ||||||
| M | 2025-12-29 | CLPR | Clipper Realty Inc. | Levinson Sam | Dir, 10% | P - Purchase | $3.71 | +58,263 | 8,923,360 | +1% | +$216,031 | |||||
| M | 2025-12-30 | STRR | Star Equity Holdings, Inc. | Eberwein Jeffrey E. | CEO, 10% | P - Purchase | $11.21 | +7,268 | 1,795,041 | 0% | +$81,503 | |||||
2025-12-30 | MSIF | Msc Income Fund, Inc. | Hyzak Dwayne L. | CEO, SMD | P - Purchase | $13.43 | +3,712 | 59,781 | +7% | +$49,852 | ||||||
| M | 2025-12-30 | MDBH | Mdb Capital Holdings, LLC | Marlett Christopher A | Co-Founder, 10% | P - Purchase | $3.26 | +8,787 | 166,720 | +6% | +$28,688 | |||||
2025-12-29 | VANI | Vivani Medical, Inc. | Mendelsohn Aaron | Dir | P - Purchase | $1.23 | +20,000 | 1,086,487 | +2% | +$24,600 | ||||||
2025-12-30 | COCP | Cocrystal Pharma, Inc. | Frost Phillip Md Et Al | Dir, 10% | P - Purchase | $0.97 | +20,000 | 1,815,651 | +1% | +$19,310 | ||||||
2025-12-30 | FSCO | Fs Credit Opportunities Corp. | Clark Della | Dir | P - Purchase | $6.22 | +3,000 | 11,368 | +36% | +$18,660 | ||||||
| M | 2025-12-29 | EP | Empire Petroleum Corp | Mulacek Phil E | Dir, 10% | P - Purchase | $3.00 | +5,451 | 8,038,529 | 0% | +$16,353 | |||||
2025-12-30 | RCG | Renn Fund, Inc. | Stahl Murray | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.61 | +1,134 | 1,001,818 | 0% | +$2,960 | ||||||
2025-12-30 | AIG | American International Group, Inc. | Inglis John C | Dir | P - Purchase | $86.47 | +14 | 2,681 | +1% | +$1,200 | ||||||
2025-12-30 | TPL | Texas Pacific Land Corp | Horizon Kinetics Asset Management LLC | 10% | P - Purchase | $294.50 | +1 | 3,487,778 | 0% | +$295 | ||||||
2025-12-29 | RCG | Renn Fund, Inc. | Kesslen Jay H | Vice-Pres | P - Purchase | $2.63 | +17 | 42,880 | 0% | +$45 | ||||||
2025-12-29 | RCG | Renn Fund, Inc. | Allen Anita L | Dir | P - Purchase | $2.64 | +5 | 658 | +1% | +$13 | ||||||
2025-12-29 | RCG | Renn Fund, Inc. | Russell Grimaldi | CCO, Secretary | P - Purchase | $2.63 | +3 | 415 | +1% | +$8 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |